Dermatology, Procedural Dermatology · Great Neck, NY
NPI
1417206459
Since 2012
Specialty
Dermatology, Procedural Dermatology
Code 207NS0135X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
255 Great Neck Rd Apt Ph15
Great Neck, NY, 11021
Phone (516) 353-7086
Groups this clinician bills Medicare through
Medicare paid, 2024
$347K
6,144 services
Medicare patients, 2024
1,556
Average age 73
Drug cost, 2024
$2.3M
1,702 prescriptions
Company payments, 2025
$4,622
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brett M Dolgin was code 17003 (destruction skin lesion), 1,692 times for 404 patients. In total Brett M Dolgin billed 6,144 services in 52 codes, and Medicare paid $347K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,692 | 404 | $5.85 | $9,906 |
| 99213 Office E&M - Established | Office | 1,252 | 946 | $72.57 | $91K |
| 17000 Destruction Skin Lesion | Office | 787 | 612 | $45.18 | $36K |
| 99214 Office E&M - Established | Office | 389 | 305 | $105.35 | $41K |
| 99203 Office E&M - New | Office | 361 | 361 | $83.03 | $30K |
| 17110 Destruction Skin Lesion | Office | 288 | 274 | $90.26 | $26K |
| 11301 Removal or Shaving of Skin Growth | Office | 241 | 195 | $95.19 | $23K |
| 11102 Skin Biopsy | Office | 185 | 163 | $73.92 | $14K |
| 99204 Office E&M - New | Office | 94 | 94 | $133.86 | $13K |
| 11103 Skin Biopsy | Office | 73 | 39 | $45.19 | $3,299 |
| 11311 Removal or Shaving of Skin Growth | Office | 71 | 70 | $116.18 | $8,249 |
| 17262 Destruction Skin Lesion | Office | 51 | 44 | $151.97 | $7,751 |
| 11302 Removal or Shaving of Skin Growth | Office | 44 | 40 | $113.69 | $5,003 |
| 11306 Removal or Shaving of Skin Growth | Office | 42 | 39 | $103.35 | $4,341 |
| 10060 Skin | Office | 34 | 34 | $115.92 | $3,941 |
By year: 2022 $261K for 4,517 services; 2023 $302K for 5,614 services; 2024 $347K for 6,144 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brett M Dolgin prescribed most often to Medicare patients was Ketoconazole, with 192 prescriptions and refills. In total Brett M Dolgin wrote 1,702 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 192 | 199 | 100 | $3,983 |
| Triamcinolone Acetonide Generic | 163 | 202 | 131 | $2,293 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 112 | 115 | 95 | $1,157 |
| Metronidazole Generic | 107 | 118 | 62 | $5,483 |
| Doxycycline Hyclate Generic | 106 | 243 | 59 | $3,872 |
| Dupixent Pen Dupilumab | 84 | 93 | 13 | $340K |
| Mometasone Furoate Generic | 70 | 70 | 59 | $1,273 |
| Fluorouracil Generic | 63 | 67 | 56 | $3,825 |
| Mupirocin Generic | 52 | 52 | 40 | $380 |
| Tremfya Guselkumab | 48 | 86 | Under 11 | $627K |
| Fluocinonide Generic | 41 | 41 | 32 | $1,588 |
| Prednisone Generic | 41 | 41 | 38 | $91.69 |
| Clindamycin Phosphate Generic | 39 | 39 | 17 | $1,244 |
| Clobetasol Propionate Generic | 38 | 39 | 25 | $2,019 |
| Hydrocortisone Generic | 35 | 38 | 29 | $175 |
Brand drugs: 346 claims; generic drugs: 1,356 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brett M Dolgin $4,622 ($4,622 in general payments such as food, travel and fees) from 20 companies. The largest payer was Arcutis Biotherapeutics, Inc. with $1,109.
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | 22 | $1,109 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $389 |
| Regeneron Healthcare Solutions, Inc. REGN | 16 | $377 |
| UCB, Inc. UCB.BR | 12 | $329 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 11 | $324 |
| Janssen Biotech, Inc. JNJ | 13 | $313 |
| Lilly USA, LLC LLY | 14 | $270 |
| Abbvie Inc. ABBV | 11 | $265 |
| LEO Pharma Inc. | 12 | $247 |
| Incyte Corporation INCY | 12 | $240 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.